Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients

Peptide-based cancer vaccines have failed to provide sufficient clinical benefits in order to be approved in clinical trials since the 1990s. To understand the mechanisms underlying this failure, the present study investigated biomarkers associated with the lower overall survival (OS) among 2,588 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Sasada, Tetsuro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Kawano, Kouichiro, Yoshiyama, Koichi, Sakamoto, Shinjiro, Sugawara, Shunichi, Komatsu, Nobukazu, Yamada, Teppei, Naito, Masayasu, Terasaki, Mizuhiko, Mine, Takashi, Itoh, Kyogo, Shichijo, Shigeki, Noguchi, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170040/
https://www.ncbi.nlm.nih.gov/pubmed/32236612
http://dx.doi.org/10.3892/ijo.2020.5019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170040/
https://www.ncbi.nlm.nih.gov/pubmed/32236612
http://dx.doi.org/10.3892/ijo.2020.5019

Ejemplares similares